The measurement of urinary amino-terminal telopeptides of type collagen to monitor bone resorption in patients with primary hyperparathyroidism

Journal of Endocrinological Investigation

Volumn 20, Issue 9, 1997, Pages 559-565

  Minisola, S ^a   Pacitti, M T ^a   Rosso, R ^a   Pellegrino, C ^a   Ombricolo, E ^a   Pisani, D ^a   Romagnoli, E ^a   Damiani, C ^a   Aliberti, G ^a   Scarda, A ^a   Mazzuoli, S F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bone mineral density; Bone turnover; N telopeptides; Primary hyperparathytoidism

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; CALCIUM ION; COLLAGEN TYPE 1; CREATININE; HYDROXYPROLINE; OSTEOCALCIN;

ACID PHOSPHATASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINO TERMINAL SEQUENCE; ARTICLE; BONE MINERAL; BONE TURNOVER; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DENSITOMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; LUMBAR SPINE; MALE; OSTEOLYSIS; PARATHYROID CARCINOMA; PATIENT MONITORING; PRIMARY HYPERPARATHYROIDISM; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN URINE LEVEL; RADIUS; SCREENING TEST; URINARY EXCRETION;

EID: 0031455271     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03348019     Document Type: Article

References (13)

1. Heath H. III. Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology. J. Bone Miner. Res. 6 (Suppl. 2): S63, 1991.
2. Minisola S., Rosso R., Romagnoli E., Pacitti M.T., Scarnecchia L., Carnevale V., Mazzuoli G.F. Trabecular bone mineral density in primary hyperparathyroidism: relationship to clinical presentation and biomarkers of skeletal turnover. Bone Miner. 20: 113, 1993.
3. Consensus Development Conference Panel. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann. Intern. Med. 114: 593, 1991.
4. Hanson D.A., Weis M.A.E., Bollen A.M., Maslan S.L., Singer F.R., Eyre D.R. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner. Res. 7: 1251, 1992.
5. Harris S.T., Gertz B.J., Eyre D.R., Genant H.K., Survill T.T., Chesnut C.H. The effect of short-term treatment with alendronate upon vertebral density and biochemical markers of bone remodeling in early postmenopausal women. J. Clin. Endocrinol. Metab. 76: 1399, 1993.
6. Gertz B.J., Shao P., Hanson D.A., Quan H., Harris S.T., Genant H.K., Chesnut III C.H., Eyre D.R. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner. Res. 9: 135, 1994.
7. Minisola S., Pacitti M.T., Scarda A., Rosso R., Romagnoli E., Carnevale V., Scarnecchia L., Mazzuoli G.F. Serum ionized calcium, parathyroid hormone and related variables: effects of age and sex. Bone Miner. 23: 183, 1993.
8. Minisola S., Romagnoli E., Scarnecchia L., Rosso R., Pacitti M.T., Scarda A., Mazzuoli G.F. Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery. Eur. J. Endocrinol. 130: 587, 1994.
9. Romagnoli E., Minisola S., Carnevale V., Scarda A., Rosso R., Scarnecchia L., Pacitti M.T., Mazzuoli G.F. Effect of estrogen deficiency on IGF-I plasma levels: relationship with bone mineral density in perimenopausal women. Calcif. Tissue Int. 53: 1, 1993.
10. Rowe J.W., Andres R., Tobin J.D., Norris A.M., Shock N.W. Age-adjusted standards for creatinine clearance. Ann. Intern. Med. 84: 567, 1976.
11. Papapoulos S.E., Frolich M., Mudde A.M., Harinck H.I.J., Berg H.V.D., Bijvoet O.L.M. Basal concentrations and response to bisphosphonate treatment. J. Clin. Endocrinol. Metab. 65: 89, 1987.
12. Thiebaud D., Jaeger P., Gobelet C., Jaquet A.F. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone. Am. J. Med. 85: 207, 1990.
13. Minisola S., Carnevale V., Pacitti M.T., Romagnoli E., Scarnecchia L., Rosso R., Minisola G., Mazzuoli G.F. Serum osteocalcin in metabolic bone disease: what is its real significance? J. Endocrinol. Invest. 16: 277, 1993.